Top compounds associated with response to TAGLN3


Feature Type Standardized
Nominal ANOVA
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.24 5e-08
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 2e-12
mRNA Epothilone B FIMM pan-cancer AAC 0.25 0.2
mRNA Erlotinib UHNBreast pan-cancer AAC 0.26 0.4
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.26 8e-13
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.26 3e-11
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.27 1e-07
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.29 2e-15
mRNA BRD-K90370028 CTRPv2 pan-cancer AAC 0.29 4e-07
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC 0.3 1e-13
Download CSV